期刊文献+

多种显像剂PET/CT鉴别大鼠C6胶质瘤与不同炎性病变的实验研究 被引量:2

Experimental study on multiple tracers PET/CT in the differentiation of C6 glioma from different inflammation
原文传递
导出
摘要 目的通过构建同时荷C6胶质瘤与不同炎性病变的大鼠模型,探讨18^F-FDG、11^C-MET和11^C-CHOPET/CT对肿瘤和不同炎性病变的鉴别诊断价值。方法(1)48只SD大鼠按随机数字表法随机分成6组,每组8只:1、2组构建同时荷右腹股沟C6胶质瘤、左上肢急性炎性病变模型;3、4组构建右腹股沟c6胶质瘤、左上肢慢性炎性病变模型;5、6组构建右腹股沟c6胶质瘤、左上肢炎性肉芽肿模型。(2)1、3及5组行11^C-MET和18^F-FDGPET/CT检查:2、4及6组行11^C-CHO和18^F-FDGPET/CT检查,分别计算3种显像剂的4种病变与正常肌肉的摄取比值及肿瘤选择指数(SI)。(3)显像后处死大鼠,取出肿瘤及炎性病变标本,进行常规病理HE染色和Glut-1、HIF-1d、CD98免疫组织化学检查。(4)两独立样本t检验统计分析每种显像剂在肿瘤和不同炎性病变中的代谢差异及肿瘤SI的差异。非参数秩和Kruskal-WallisH检验分析免疫组织化学指标在不同病变间的表达率差异,组间两两比较用Nemenyi法检验。结果(1)18^F-FDG、11^C-MET在C6胶质瘤中的代谢程度均高于3种炎性病变,且差异有统计学意义(t=1.425~3.901,均P〈0.05)。11^C-CHO代谢程度在各种病变之间差异均无统计学意义(t=0.031-3.901,均P〉0.05)。在肿瘤+急性炎性病变模型中,SIMET(4.22±2.96)大于SIFDC(1.77±0.86),差异有统计学意义(t=2.717,P〈0.05);在肿瘤+肉芽肿模型中,SIMET(4.89±2.08)大于SIFDG(1.72±0.77),差异有统计学意义(t=2.490,P〈0.05);在肿瘤+慢性炎性病变模型中,SIMET(3.84±2.71)大于SIFDG(2.28±1.14),但差异无统计学意义(t=2.082,P〉0.05)。(2)不同病变的Glut-1表达率组间差异无统计学意义(H=5.940,P〉0.05),HIF-1d及CD98表达率组间差异均有统计学意义(H=17.810、26.540,均P〈0.05)。 Objective To investigate the value of 18F-FDG, 11C-MET and 11C-CHO PET/CT in the differentiation of C6 glioma from different kinds of inflammation in experimental rat models. Methods ( 1 ) A total of 48 male SD rats were randomly divided into 6 groups by the random number table : group 1 and 2 consisted of 8 rats bearing both C6 glioma and turpentine oil-induced acute inflammation ; group 3 and 4 consisted of 8 rats bearing both C6 glioma and turpentine oil-induced chronic inflammation; group 5 and 6 consisted of 8 rats bearing both C6 glioma and BCG-induced granuloma. (2) 18F-FDG and 11 C-MET PET/CT were performed on rats of group 1, 3 and 5; 18F-FDG and 11C-CHO PET/CT were performed on rats of group 2, 4 and 6. The lesion-to-muscle ratios and tumor selectivity index (SI) were calculated. (3) Afterthe PET/CT imaging, the lesions were excised. Immunohistochemical staining was used to demonstrate the situation of Glut-l, HIF-1α and CD98. (4)Two-sample t test, Nemenyi test and nonparametric Kruskal- Wallis H test were used for statistical analyses. Results ( 1 ) XSF_FDG and 11 C-MET uptake in C6 glioma were higher than those in different inflammatory tissues(t= 1.425-3.901, all P〈0.05). The 11C-CHO up- take among different lesions were not significant (t = 0.031-3.901, all P〉0.05). In group 1 and 5 models, SIMET(4.22±2.96 and 4.89±2.08) was significantly higher than SIFDG( 1.77±0.86 and 1.72±0.77; t=2.717 and 2.490, both P〈0.05) ; but in group 3 models, SIMET( 3.84±2.71 ) was not significantly higher than SIFDG(2.28± 1.14 ; t = 2.082, P〉0.05 ). (2) Immunohistochemical study showed that there were significant differences in the expression of HIF-1α, CD98 among different lesions (H= 17.810, 26.540, both P〈 0. 05), and no significances of expression of Glut-1 among different lesions (H= 5.940, P〉0.05). Nemenyi test showed that there was significant difference for CD98 expression between C6 glioma and acute inflamma- tion, C6 glioma and g
出处 《中华核医学与分子影像杂志》 北大核心 2015年第5期396-402,共7页 Chinese Journal of Nuclear Medicine and Molecular Imaging
关键词 神经胶质瘤 炎症 体层摄影术 发射型计算机 脱氧葡萄糖 甲硫氨酸 胆碱 大鼠 Glioma Inflammation Tomography, emisssion-computed Deoxyglucose Methionine Choline Rats
  • 相关文献

参考文献24

  • 1Deng H, Tang X, Wang H, et al. S-11 C-methyl-L-cysteine: a newamino acid PET tracer for cancer imaging[ J]. J Nucl Med, 2011,52(2) : 287-293. 被引量:1
  • 2理东丽,许乙凯,王全师,吴湖炳,李洪生,王巧愚.^11C—MET和^18F—FDG PET/CT诊断胶质瘤术后残余或复发的比较[J].中华核医学杂志,2011,31(4):233-236. 被引量:11
  • 3Wehrl HF, Schwab J,Hasenbach K, et al. Multimodal elucidationof choline metabolism in a murine glioma model using magnetic res-onance spectroscopy and "C-choline positron emission tomography[J]. Cancer Res, 2013,73(5) : 1470-1480. 被引量:1
  • 4李伟龙,邢喜玲,蔡莉,刘桂超,李彦生,高硕.大鼠C6胶质瘤放射治疗前后^18F—FDG摄取水平变化与多种生物学指标的相关性研究[J].中华核医学杂志,2011,31(6):368-372. 被引量:3
  • 5Toyohara J,Sakata M, Oda K,et al. Longitudinal observation of[llC]4DST uptake in turpentine-induced inilainmatory tissuef J].Nucl Med Biol, 2013,40(2) : 240-244. 被引量:1
  • 6Borbely K,Wintermark M, Martos J,et al. The pre-requisite of asecond-generation glioma PET biomarker[ J]. J Neurol Sci,2010,298(1-2) ; 11-16. 被引量:1
  • 7Oka S, Okudaira H, Ono M, et al. Differences in transport mecha-nisms of trans-1 -amino-3-[ 18 F] fluorocyclobutanecarboxylic acid ininflammation, prostate cancer, and ^ioma cells : comparison withL-[ methyl-11 C ] methionine and 2-deoxy-2-[ 18 F] fluoro-D-glucose[J]. Mol Imaging Biol, 2014, 16(3); 322-329. 被引量:1
  • 8Treglia G, Giovannini E,Di Franco D, et al. The role of positronemission tomography using carbon-11 and fluorine-18 choline intumors other than prostate cancer ; a systematic review [ J ]. AnnNucl Med, 2012, 26(6) : 451-461. 被引量:1
  • 9Walmsley SR, Print C, Farahi N, et al. Hypoxia-induced neutro-phil survival is mediated by HIF-1 alpha-dependent NF-kappaB ac-tivity [J]. J Exp Med, 2005, 201(1): 105-115. 被引量:1
  • 10Kracht LW, Friese M,Heriiolz K, et al. Methyl-[11 C]-1-methio-nine uptake as measured by positron emission tomography correlatesto microvessel density in patients with glioma[ J] - Eur J Nucl MedMol Imaging, 2003,30(6) : 868-873. 被引量:1

二级参考文献63

  • 1赵辉,王俊,李剑锋,刘军,李运,刘彦国,陈应泰.纵隔镜检查在胸部结节病诊断中的价值[J].中华医学杂志,2005,85(13):919-921. 被引量:22
  • 2王全师,吴湖炳,王明芳,王欣璐,郭晓君.^(11)C-蛋氨酸PET/CT显像在脑胶质瘤中的初步应用[J].中华核医学杂志,2005,25(5):286-287. 被引量:10
  • 3Ogawa T, Kanno I, Shishido F, et al. Clinical value of PET with ^18 F-fluorodeoxyglucose and L-methyl- ^11 C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol, 1991, 32 : 197-202. 被引量:1
  • 4Singhal T, Narayanan TK, Jain V, et al. ^11C-L-methionine posi- tron emission tomography in the clinical management of cerebral gli- omas. Mol Imaging Biol, 2008, 10: 1-18. 被引量:1
  • 5Okita Y, Kinoshita M, Goto T, et al. ^11C-methionine uptake cor- relates with tumor cell density rather than with microvessel density in glioma: a stereotactic image-histology comparison. Neuro Image, 2010, 49 : 2977-2982. 被引量:1
  • 6Jager PL, Vaalburg W, Pruim J, et al. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med, 2001,42 : 432-445. 被引量:1
  • 7Pirotte B, Goldman S, Massager N, et al. Combined use of ^18F- fluorodeoxyglucose and ^11C-methionine in 45 positron emission tomography-guided stereotaetic brain biopsies. J Neurosurg, 2004, 101 : 476-483. 被引量:1
  • 8Pirotte B, Goldman S, Massager N, et al. Comparison of ^18F-FDG and ^11 C-methionine for PET-guided stereotactic brain biopsy of gli- omas. J Nucl Med, 2004, 45: 1293-1298. 被引量:1
  • 9Braga FJHN, Flamen P, Van Calenbergn F. ^11C-methionine (MET) and ^18 F-FDG PET for the evaluation of suspected recur- rent brain tumous (SRBT). Eur J Nucl Med Mol Imaging, 2000, 27 : 1145. 被引量:1
  • 10Van Laere K, Ceyssens S, Van Calenbergh F, et al. Direct com- parison of ^18F-FDG and ^11C-methionine PET in suspected recur- rence of glioma: sensitivity, inter-observer variability and prognos- tic value. Eur J Nucl Med Mol Imaging, 2005, 32: 39-51. 被引量:1

共引文献24

同被引文献9

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部